|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/28/20 Norbe Todd 4 Dir.,Off.² 1:5K Biolase, Inc. DONNELLEY FIN… File16/FA
5/28/20 Beaver John R 4 Officer² 1:5K Biolase, Inc. DONNELLEY FIN… File16/FA
5/28/20 Wagner Elaine C 4 Director² 1:6K Biolase, Inc. DONNELLEY FIN… File16/FA
5/28/20 Sato Garrett 4 Director² 1:6K Biolase, Inc. DONNELLEY FIN… File16/FA
5/28/20 DiTolla Michael 4 Director² 1:6K Biolase, Inc. DONNELLEY FIN… File16/FA
5/28/20 Lanman Richard B. 4 Director² 1:7K Biolase, Inc. DONNELLEY FIN… File16/FA
5/28/20 Roper Jess 4 Director² 1:6K Biolase, Inc. DONNELLEY FIN… File16/FA
5/28/20 Lord Jonathan T MD 4 Director² 1:6K Biolase, Inc. DONNELLEY FIN… File16/FA
5/15/20 Biolase, Inc. 8-K:5 5/13/20 1:71K ActiveDisclosure/FA
4/23/20 Biolase, Inc. DEF 14A 5/13/20 1:1.5M ActiveDisclosure/FA
4/13/20 Biolase, Inc. PRE 14A 5/13/20 1:1.5M ActiveDisclosure/FA
____________ | ¹ | Filing/Form Types: /A | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | | PRE 14A | Preliminary Proxy Statement — Schedule 14A. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|